Course - Brussels, Belgium
By attending this course, you will:
1. Know what determines the value of life science biotechs and emerging pharma companies.
2. Gain a thorough understanding of key valuation terms, concepts, tools & techniques.
3. Learn and practice how to:
1. Know what determines the value of life science biotechs and emerging pharma companies.
2. Gain a thorough understanding of key valuation terms, concepts, tools & techniques.
3. Learn and practice how to:
- Use a model that assesses the soft factors of a biotech company prior to its valuation.
- Calculate the value of a biotech company.
- Calculate the value of a development compound with an excel tool you can take home and use for any other pharmaceutical product in development.
- Structure licensing deals between pharma and biotech, covering issues such as milestones and royalty payments.
4. Gain expert insight and advice from Patrik Frei who has assessed and valued numerous products and companies in the life sciences industry.
Programme outline
- Welcome & Introduction to Valuation: What – Why – When
- How to Assess a Company Prior to Valuation
- Company Valuation: Interactive lecture & Group work on a case study
- Product Valuation & Deal Structuring: Interactive lecture & Group work on a case study
- Final Discussion & Wrap-up
- Organization: C.E.L.forpharma
Thu, Oct 22, 2015 - Thu, Oct 22, 2015
Sheraton Brussels Airport Hotel
Brussels National Airport, Brussels, Belgium
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
